Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
174,282,170
-
Total 13F shares
-
49,517,421
-
Share change
-
+3,386,163
-
Total reported value
-
$472,282,828
-
Put/Call ratio
-
9.8%
-
Price per share
-
$9.54
-
Number of holders
-
82
-
Value change
-
+$28,502,950
-
Number of buys
-
46
-
Number of sells
-
19
Institutional Holders of Prime Medicine, Inc. - COMMON STOCK (PRME) as of Q3 2023
As of 30 Sep 2023 Prime Medicine, Inc. - COMMON STOCK (PRME) had 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 49,517,421 shares of stock of the company.
Largest 10 holders included Alphabet Inc., VANGUARD GROUP INC, FMR LLC, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., BlackRock Inc., ARK Investment Management LLC, PRICE T ROWE ASSOCIATES INC /MD/, FIL Ltd, and MWG Management Ltd..
This table shows 82 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.